These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 25398427)

  • 1. Physicochemical and formulation developability assessment for therapeutic peptide delivery--a primer.
    Bak A; Leung D; Barrett SE; Forster S; Minnihan EC; Leithead AW; Cunningham J; Toussaint N; Crocker LS
    AAPS J; 2015 Jan; 17(1):144-55. PubMed ID: 25398427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomal delivery of proteins and peptides.
    Swaminathan J; Ehrhardt C
    Expert Opin Drug Deliv; 2012 Dec; 9(12):1489-503. PubMed ID: 23092138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review on parenteral delivery of peptides and proteins.
    Jain D; Mahammad SS; Singh PP; Kodipyaka R
    Drug Dev Ind Pharm; 2019 Sep; 45(9):1403-1420. PubMed ID: 31215293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospects of formulating proteins/peptides as aerosols for pulmonary drug delivery.
    Shoyele SA; Slowey A
    Int J Pharm; 2006 May; 314(1):1-8. PubMed ID: 16563674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel delivery technologies for protein and peptide therapeutics.
    Kumar TR; Soppimath K; Nachaegari SK
    Curr Pharm Biotechnol; 2006 Aug; 7(4):261-76. PubMed ID: 16918403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive systemic drug delivery: developability considerations for alternate routes of administration.
    Mathias NR; Hussain MA
    J Pharm Sci; 2010 Jan; 99(1):1-20. PubMed ID: 19499570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges in the delivery of peptide drugs: an industry perspective.
    Lewis AL; Richard J
    Ther Deliv; 2015 Feb; 6(2):149-63. PubMed ID: 25690084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral Delivery of Therapeutic Proteins and Peptides: An Overview of Current Technologies and Recommendations for Bridging from Approved Intravenous or Subcutaneous Administration to Novel Oral Regimens.
    Philippart M; Schmidt J; Bittner B
    Drug Res (Stuttg); 2016 Mar; 66(3):113-20. PubMed ID: 26536331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of intranasally delivered peptides: key considerations for pharmaceutical development.
    Al Bakri W; Donovan MD; Cueto M; Wu Y; Orekie C; Yang Z
    Expert Opin Drug Deliv; 2018 Oct; 15(10):991-1005. PubMed ID: 30173579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation Approaches to Overcome Biopharmaceutical Limitations of Inhaled Peptides/Proteins.
    Onoue S; Suzuki H; Seto Y
    Curr Pharm Des; 2015; 21(27):3867-74. PubMed ID: 26290195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smart polymers for controlled delivery of proteins and peptides: a review of patents.
    Fogueri LR; Singh S
    Recent Pat Drug Deliv Formul; 2009 Jan; 3(1):40-8. PubMed ID: 19149728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of particulate drug delivery systems for oral delivery of Peptide and protein drugs.
    Christophersen PC; Fano M; Saaby L; Yang M; Nielsen HM; Mu H
    Curr Pharm Des; 2015; 21(19):2611-28. PubMed ID: 25876916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and characterisation of dissolving microneedles for the transdermal delivery of therapeutic peptides.
    Dillon C; Hughes H; O'Reilly NJ; McLoughlin P
    Int J Pharm; 2017 Jun; 526(1-2):125-136. PubMed ID: 28461268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Buccal bioadhesive drug delivery--a promising option for orally less efficient drugs.
    Sudhakar Y; Kuotsu K; Bandyopadhyay AK
    J Control Release; 2006 Aug; 114(1):15-40. PubMed ID: 16828915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging delivery platforms for mucosal administration of biopharmaceuticals: a critical update on nasal, pulmonary and oral routes.
    Thwala LN; Préat V; Csaba NS
    Expert Opin Drug Deliv; 2017 Jan; 14(1):23-36. PubMed ID: 27351299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymer-drug conjugates: recent progress on administration routes.
    Pang X; Yang X; Zhai G
    Expert Opin Drug Deliv; 2014 Jul; 11(7):1075-86. PubMed ID: 24758250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in protein and Peptide drug delivery: a special emphasis on polymeric nanoparticles.
    Patel A; Patel M; Yang X; Mitra AK
    Protein Pept Lett; 2014; 21(11):1102-20. PubMed ID: 25106908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel formulations and drug delivery systems to administer biological solids.
    Zhang Y; Davis DA; AboulFotouh K; Wang J; Williams D; Bhambhani A; Zakrewsky M; Maniruzzaman M; Cui Z; Williams RO
    Adv Drug Deliv Rev; 2021 May; 172():183-210. PubMed ID: 33705873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide Developability at the Discovery-to-Development Interface--Current State and Future Opportunities.
    Bak A; Dai W
    AAPS J; 2015 Jul; 17(4):777-9. PubMed ID: 25823670
    [No Abstract]   [Full Text] [Related]  

  • 20. Just how prevalent are peptide therapeutic products? A critical review.
    Zhang Y; Zhang H; Ghosh D; Williams RO
    Int J Pharm; 2020 Sep; 587():119491. PubMed ID: 32622810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.